Search research articles
Contact Us
Filters
Showing results (211-220 of 358) with videos related to
Page
of 36
Sort By:
Ebiomedicine
|
January 20, 2015
Vaccine-induced Human Antibodies Specific for the Third Variable Region of HIV-1 gp120 Impose Immune Pressure on Infecting Viruses
Susan Zolla-Pazner, Paul T Edlefsen, Morgane Rolland, et al.
Plos One
|
December 30, 2011
Safety and reactogenicity of canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E vaccination in an efficacy trial in Thailand
Punnee Pitisuttithum, Supachai Rerks-Ngarm, Valai Bussaratid, et al.
AIDS (London, England)
|
February 1, 2023
Brain volumetrics differ by Fiebig stage in acute HIV infection
Jacob Bolzenius, Carlo Sacdalan, Lishomwa C Ndhlovu, et al.
Nature Immunology
|
September 24, 2021
The transcription factor CREB1 is a mechanistic driver of immunogenicity and reduced HIV-1 acquisition following ALVAC vaccination
Jeffrey Alan Tomalka, Adam Nicolas Pelletier, Slim Fourati, et al.
Ebiomedicine
|
November 8, 2023
Tracking coreceptor switch of the transmitted/founder HIV-1 identifies co-evolution of HIV-1 antigenicity, coreceptor usage and CD4 subset targeting: the RV217 acute infection cohort study
Manukumar Honnayakanahalli Marichannegowda, Michelle Zemil, Lindsay Wieczorek, et al.
Plos One
|
July 6, 2017
V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144
Lautaro G Perez, David R Martinez, Allan C deCamp, et al.
Journal of Virology
|
April 12, 2013
Molecular evolution of the HIV-1 Thai epidemic between the time of RV144 immunogen selection to the execution of the vaccine efficacy trial
Gustavo H Kijak, Sodsai Tovanabutra, Supachai Rerks-Ngarm, et al.
Science Translational Medicine
|
February 17, 2017
Delayed differentiation of potent effector CD8<sup>+</sup> T cells reducing viremia and reservoir seeding in acute HIV infection
Hiroshi Takata, Supranee Buranapraditkun, Cari Kessing, et al.
Biorxiv : the Preprint Server for Biology
|
January 30, 2023
Tracking coreceptor switch of the transmitted/founder HIV-1 identifies co-evolution of HIV-1 antigenicity, coreceptor usage and CD4 subset targeting
Manukumar Honnayakanahalli Marichannegowda, Michelle Zemil, Lindsay Wieczorek, et al.
Journal of the International AIDS Society
|
August 29, 2025
High peak viraemia followed by spontaneous HIV-1 control in women living with HIV-1 subtype A1 in East Africa
Yifan Li, Bethany L Dearlove, Eric Lewitus, et al.
Page
of 36
Search research articles
Search
Showing results (211-220 of 358) with videos related to
Sort By:
Page
of 36
Ebiomedicine
|
January 20, 2015
Vaccine-induced Human Antibodies Specific for the Third Variable Region of HIV-1 gp120 Impose Immune Pressure on Infecting Viruses
Susan Zolla-Pazner, Paul T Edlefsen, Morgane Rolland, et al.
Plos One
|
December 30, 2011
Safety and reactogenicity of canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E vaccination in an efficacy trial in Thailand
Punnee Pitisuttithum, Supachai Rerks-Ngarm, Valai Bussaratid, et al.
AIDS (London, England)
|
February 1, 2023
Brain volumetrics differ by Fiebig stage in acute HIV infection
Jacob Bolzenius, Carlo Sacdalan, Lishomwa C Ndhlovu, et al.
Nature Immunology
|
September 24, 2021
The transcription factor CREB1 is a mechanistic driver of immunogenicity and reduced HIV-1 acquisition following ALVAC vaccination
Jeffrey Alan Tomalka, Adam Nicolas Pelletier, Slim Fourati, et al.
Ebiomedicine
|
November 8, 2023
Tracking coreceptor switch of the transmitted/founder HIV-1 identifies co-evolution of HIV-1 antigenicity, coreceptor usage and CD4 subset targeting: the RV217 acute infection cohort study
Manukumar Honnayakanahalli Marichannegowda, Michelle Zemil, Lindsay Wieczorek, et al.
Plos One
|
July 6, 2017
V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144
Lautaro G Perez, David R Martinez, Allan C deCamp, et al.
Journal of Virology
|
April 12, 2013
Molecular evolution of the HIV-1 Thai epidemic between the time of RV144 immunogen selection to the execution of the vaccine efficacy trial
Gustavo H Kijak, Sodsai Tovanabutra, Supachai Rerks-Ngarm, et al.
Science Translational Medicine
|
February 17, 2017
Delayed differentiation of potent effector CD8<sup>+</sup> T cells reducing viremia and reservoir seeding in acute HIV infection
Hiroshi Takata, Supranee Buranapraditkun, Cari Kessing, et al.
Biorxiv : the Preprint Server for Biology
|
January 30, 2023
Tracking coreceptor switch of the transmitted/founder HIV-1 identifies co-evolution of HIV-1 antigenicity, coreceptor usage and CD4 subset targeting
Manukumar Honnayakanahalli Marichannegowda, Michelle Zemil, Lindsay Wieczorek, et al.
Journal of the International AIDS Society
|
August 29, 2025
High peak viraemia followed by spontaneous HIV-1 control in women living with HIV-1 subtype A1 in East Africa
Yifan Li, Bethany L Dearlove, Eric Lewitus, et al.
Page
of 36